Modulight: Growth not picking up yet
The Q2 report was disappointing compared to our expectations and the market reaction was also strongly negative. The company's revenue of EUR 1.1 million was modest, especially when considering the large contract that still supported the figures in this quarter. We are lowering our estimates for the short and long term in view of the difficulties in the business and the continuing very low visibility. Despite the fall in the share price, the valuation seems even more challenging than before, as in addition to our estimates, our view on the acceptable multiples for the stock has gone down.
Modulight
Modulight operates in the technology industry. The company designs, markets, and produces biomedical laser products used in oncology, genetics, and ophthalmology. The customers primarily consist of hospitals and corporate customers operating in medical technology. In addition to the main business, various value-added services are also offered. Their main market is the US.
Read more on company pageKey Estimate Figures21.08.2023
2022 | 23e | 24e | |
---|---|---|---|
Revenue | 4.6 | 5.8 | 8.4 |
growth-% | -49.3 % | 26.1 % | 44.4 % |
EBIT (adj.) | -7.8 | -6.0 | -3.2 |
EBIT-% (adj.) | -169.5 % | -103.3 % | -37.9 % |
EPS (adj.) | -0.20 | -0.13 | -0.07 |
Dividend | 0.00 | 0.00 | 0.00 |
Dividend % | |||
P/E (adj.) | - | - | - |
EV/EBITDA | - | - | - |